News
The stock's fall snapped a four-day winning streak.
7h
Zacks Investment Research on MSNWill The Decline in Legacy Drugs Pull Down BMY's Top Line?Bristol Myers’ BMY legacy portfolio comprises Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane. Revenues for the Legacy ...
Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for ...
UBS reaffirmed its Buy rating and $105 target for Merck, brushing off investor pessimism about the pharmaceutical giant’s ...
Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...
2d
DPA International on MSNGerman pharma giant Merck takes over US cancer specialistGerman pharmaceutical giant Merck has completed a €3 billion ($3.5 billion) takeover of US biopharmaceutical company ...
Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis ...
The Dow Dow Jones Industrial Average was most recently trading 492 points higher (1.1%), as shares of Amgen Amgen Inc. and Merck Merck & Co. Inc. have contributed around 25% of the blue-chip gauge's ...
Law enforcement agencies from across Southern Oregon gathered Monday to honor Jackson County Sheriff’s Corrections Deputy Kenneth “KC” Merck, who died unexpectedly on June 17, 2025, following a sudden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results